Asher Begleiter

2.9k total citations
99 papers, 2.5k citations indexed

About

Asher Begleiter is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Asher Begleiter has authored 99 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 36 papers in Toxicology and 31 papers in Organic Chemistry. Recurrent topics in Asher Begleiter's work include Bioactive Compounds and Antitumor Agents (36 papers), Cancer therapeutics and mechanisms (22 papers) and Synthesis and Biological Evaluation (17 papers). Asher Begleiter is often cited by papers focused on Bioactive Compounds and Antitumor Agents (36 papers), Cancer therapeutics and mechanisms (22 papers) and Synthesis and Biological Evaluation (17 papers). Asher Begleiter collaborates with scholars based in Canada, United States and Israel. Asher Begleiter's co-authors include Gerald J. Goldenberg, Marsha K. Leith, James B. Johnston, Michael Mowat, Amos Buchner, Douglas S. Johnson, Lyonel G. Israels, Hing-Yat Peter Lam, J. W. LOWN and A. Richard Morgan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Asher Begleiter

99 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asher Begleiter Canada 31 1.5k 506 496 494 297 99 2.5k
Joseph M. Covey United States 29 2.4k 1.6× 347 0.7× 802 1.6× 320 0.6× 146 0.5× 88 3.0k
Andrzej Składanowski Poland 27 2.1k 1.4× 283 0.6× 1.1k 2.2× 548 1.1× 48 0.2× 62 2.9k
Panayotis Pantazis United States 36 2.5k 1.7× 197 0.4× 1.2k 2.4× 192 0.4× 77 0.3× 93 3.7k
Jan M. Woynarowski United States 24 1.5k 1.0× 134 0.3× 1.5k 3.0× 414 0.8× 75 0.3× 56 2.8k
Caroline A. Austin United Kingdom 40 4.5k 3.0× 664 1.3× 1.8k 3.7× 727 1.5× 78 0.3× 135 5.4k
Akihiro Tomida Japan 35 2.3k 1.6× 122 0.2× 929 1.9× 254 0.5× 95 0.3× 99 3.6k
Ali Bettaı̈eb France 39 2.2k 1.5× 78 0.2× 733 1.5× 274 0.6× 185 0.6× 132 4.0k
Tomoko Oh‐hara Japan 31 2.0k 1.3× 118 0.2× 1.7k 3.5× 237 0.5× 101 0.3× 65 3.4k
Silvia Schenone Italy 43 2.5k 1.7× 165 0.3× 737 1.5× 3.1k 6.3× 388 1.3× 236 5.9k
Sherman F. Stinson United States 26 959 0.7× 59 0.1× 629 1.3× 473 1.0× 113 0.4× 57 2.2k

Countries citing papers authored by Asher Begleiter

Since Specialization
Citations

This map shows the geographic impact of Asher Begleiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Begleiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Begleiter more than expected).

Fields of papers citing papers by Asher Begleiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asher Begleiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Begleiter. The network helps show where Asher Begleiter may publish in the future.

Co-authorship network of co-authors of Asher Begleiter

This figure shows the co-authorship network connecting the top 25 collaborators of Asher Begleiter. A scholar is included among the top collaborators of Asher Begleiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asher Begleiter. Asher Begleiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Begleiter, Asher, et al.. (2009). A Model for NAD(P)H: Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy. SHILAP Revista de lepidopterología. 4. DTI.S1146–DTI.S1146. 8 indexed citations
2.
Begleiter, Asher, Kimberly Larson, Jennifer K. Lang, et al.. (2006). Structure-activity studies with cytotoxic anthrapyrazoles. Oncology Reports. 15(6). 1575–80. 9 indexed citations
3.
Bird, Ranjana P., et al.. (2005). Effect of post-initiation induction of NQO1 by oltipraz on AOM induced colon tumor formation in Sprague-Dawley rats. Cancer Research. 65. 581–581. 3 indexed citations
4.
Begleiter, Asher, Teresa Cabral, Donna Hewitt, et al.. (2005). Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neck. Oral Oncology. 41(9). 927–933. 16 indexed citations
5.
Blakley, Brian W., et al.. (2005). Effect of Sodium Thiosulphate and cis-Diamminedichloroplatinum on FADU Tumour Cells in Nude Mice. The Journal of Otolaryngology. 34(6). 371–371. 1 indexed citations
6.
Hasinoff, Brian B., Xing Wu, Asher Begleiter, et al.. (2005). Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II. Cancer Chemotherapy and Pharmacology. 57(2). 221–233. 22 indexed citations
7.
Begleiter, Asher, et al.. (2004). Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo. British Journal of Cancer. 91(8). 1624–1631. 31 indexed citations
8.
Begleiter, Asher, et al.. (2003). Induction of NAD(P)H Quinone. Cancer Epidemiology and Prevention Biomarkers. 12(6). 566–572. 1 indexed citations
9.
10.
Johnston, James B., et al.. (2003). Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia. Oncogene. 22(51). 8356–8369. 46 indexed citations
11.
Begleiter, Asher. (2000). Clinical applications of quinone-containing alkylating agents. Frontiers in bioscience. 5(1). e153–e153. 51 indexed citations
12.
Littner, M.M., I Kaffe, A Tamse, & Asher Begleiter. (1997). Prophylaxis of bacterial endocarditis. PharmacoEconomics & Outcomes News. 118(1). 5–5. 1 indexed citations
13.
Johnston, James B., Paul Daeninck, G. J. Williams, et al.. (1997). P53, MDM-2, BAX and BCL-2 and Drug Resistance in Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 26(5-6). 435–449. 64 indexed citations
14.
Thliveris, James A., et al.. (1997). IMMUNOTHERAPY FOR INSULIN-DEPENDENT DIABETES MELLITUS IN THE “BB” RAT. Life Sciences. 61(3). 283–291. 1 indexed citations
15.
Plunkett, W., Asher Begleiter, Jan Liliemark, & John C. Reed. (1996). Why Do Drugs Work in CLL?. Leukemia & lymphoma. 22(sup2). 1–11. 12 indexed citations
16.
Begleiter, Asher, et al.. (1995). Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.. PubMed. 9(11). 1875–81. 25 indexed citations
17.
Begleiter, Asher, et al.. (1993). Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.. Molecular Pharmacology. 44(1). 210–215. 17 indexed citations
18.
Johnston, James B., et al.. (1992). Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2′-deoxycoformycin. Leukemia Research. 16(8). 781–788. 23 indexed citations
19.
Begleiter, Asher, et al.. (1992). Inhibition of repair of bleomycin-induced DNA strand breaks by 2'-deoxycoformycin and its effect on antitumor activity in 15178Y lymphoblasts. Biochemical Pharmacology. 44(11). 2229–2233. 1 indexed citations
20.
Buchner, Amos, Yochanan Ramon, & Asher Begleiter. (1979). Chondrosarcoma of the maxilla: report of case.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(11). 822–5. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph M. Covey Breakdown of academic impact, for papers by Andrzej Składanowski Breakdown of academic impact, for papers by Panayotis Pantazis Breakdown of academic impact, for papers by Jan M. Woynarowski Breakdown of academic impact, for papers by Caroline A. Austin Breakdown of academic impact, for papers by Akihiro Tomida Breakdown of academic impact, for papers by Ali Bettaı̈eb Breakdown of academic impact, for papers by Tomoko Oh‐hara Breakdown of academic impact, for papers by Silvia Schenone Breakdown of academic impact, for papers by Sherman F. Stinson
Rankless by CCL
2026